United States · 
Who invested in Avitide?
Avitide's investors include Polaris Partners, OrbiMed, SV Life Sciences, Borealis Ventures and NeoMed.
2015
$3.4MVenture$7.6MSeries CUnited States · Series C startup
Who invested in Avitide
2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$11Mraised across 2 rounds since 2014, from 2 sources
$3.4MVenture$7.6MSeries C
- Latest round
- Series C, $7.6MAug 2015
- Step-upi
- 2.2×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $3.4M Jun 2014
- Biggest round
- $7.6M Series C · Aug 2015
- Between rounds
- 14 months from the last two
The rounds
- Aug 2015Series C$7.6M5 new
From a historical funding recordSEC filing: $3.8M sold, first sale Jul 2015
- Jun 2014Venture$3.4M
No investor was named in the report.
From a historical funding recordSEC filing: $3.4M sold, first sale May 2014
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
SV Life SciencesVC firm1round
NeoMedGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Avitide
How much has Avitide raised?
Avitide has raised $11M across 2 rounds since 2014.
When did Avitide last raise?
Avitide's most recent round was a Series C of $7.6M in Aug 2015.
What was Avitide's biggest round?
Its most recent round, $7.6M in Aug 2015, is also its largest on record.
Who backed Avitide first?
Avitide's first round on record, in Aug 2015, was backed by Polaris Partners, OrbiMed and SV Life Sciences and 2 others.
What stage is Avitide at?
Avitide's latest named round is a Series C, in Aug 2015.
Where is Avitide based?
Avitide is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.